Peptide record

TPDB47133

ACE inhibitor ACE inhibitors Antihypertensive standard
10 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB47133
ACE inhibitor
ACE inhibitors Antihypertensive
Cardiometabolic peptides
pep-lab Peptipedia AHTPDB AHTpin
standard
No
A 10-aa standard natural multi-activity (ACE inhibitors and Antihypertensive) peptide sequence curated from pep-lab, Peptipedia, AHTPDB, and other sources, with an available 3D structural model.
Sequence
TDQHQDKIYP
Physicochemical Analysis
C54H81N15O19
ARNCEGLMFSWV
DQ
1244.33
5.10
2
2
2
-1
4.91
-2.020
39.00
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
1490
119.74
4
Residue Composition
number
0
A
0
R
0
N
2
D
0
C
0
E
2
Q
0
G
1
H
1
I
0
L
1
K
0
M
0
F
1
P
0
S
1
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 2 C: 0 E: 0 Q: 2 G: 0 H: 1 I: 1 L: 0 K: 1 M: 0 F: 0 P: 1 S: 0 T: 1 W: 0 Y: 1 V: 0
Chemical Descriptors
10
C54H81N15O19
1244.33
5.10
-1
4.91
-2.020
1244.3068
1243.5814
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
380.00 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

NA
Kohmura M., Nio N., Kubo K., Minoshima Y., Munekata E., Ariyoshi Y.
Inhibition of angiotensin-converting enzyme by synthetic peptides of human beta-casein. Agric. Biol. Chem., 53(8), 2107-2114 (1989)
1989
Journal

Other

10
BIOPEP-UWM database of bioactive peptides SMILES: [H][C@@](CCCCN)(NC(=O)[C@]([H])(CC(O)=O)NC(=O)[C@]([H])(CCC(N)=O)NC(=O)[C@]([H])(Cc1cnc[nH]1)NC(=O)[C@]([H])(CCC(N)=O)NC(=O)[C@]([H])(CC(O)=O)NC(=O)[C@@]([H])(N)[C@@H](C)O)C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N1CCC[C@@]1([H])C(O)=O InChI=1S/C54H81N15O19/c1-4-26(2)44(52(85)67-37(20-28-10-12-30(71)13-11-28)53(86)69-19-7-9-38(69)54(87)88)68-47(80)31(8-5-6-18-55)61-49(82)35(22-41(74)75)65-46(79)33(15-17-40(57)73)62-48(81)34(21-29-24-59-25-60-29)64-45(78)32(14-16-39(56)72)63-50(83)36(23-42(76)77)66-51(84)43(58)27(3)70/h10-13,24-27,31-38,43-44,70-71H,4-9,14-23,55,58H2,1-3H3,(H2,56,72)(H2,57,73)(H,59,60)(H,61,82)(H,62,81)(H,63,83)(H,64,78)(H,65,79)(H,66,84)(H,67,85)(H,68,80)(H,74,75)(H,76,77)(H,87,88)/t26-,27+,31-,32-,33-,34-,35-,36-,37-,38-,43-,44-/m0/s1 InChIKey: VTJZYUHCIFXLFY-DKZBFBCOSA-N Information concerning Angiotensin-Converting Enzyme (ACE) is available in MEROPS database of proteolytic enzymes (http://merops.sanger.ac.uk/) ID: M02-001
Evidence 2 Activity

Activity

IC50
Antihypertensive
380.00 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

AHTPDB
Kohmura M., Nio N., Kubo K., Minoshima Y., Munekata E., Ariyoshi Y.
Inhibition of angiotensin-converting enzyme by synthetic peptides of human beta-casein. Agric. Biol. Chem., 53(8), 2107-2114 (1989)
1989
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
10
BIOPEP-UWM database of bioactive peptides SMILES: [H][C@@](CCCCN)(NC(=O)[C@]([H])(CC(O)=O)NC(=O)[C@]([H])(CCC(N)=O)NC(=O)[C@]([H])(Cc1cnc[nH]1)NC(=O)[C@]([H])(CCC(N)=O)NC(=O)[C@]([H])(CC(O)=O)NC(=O)[C@@]([H])(N)[C@@H](C)O)C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N1CCC[C@@]1([H])C(O)=O InChI=1S/C54H81N15O19/c1-4-26(2)44(52(85)67-37(20-28-10-12-30(71)13-11-28)53(86)69-19-7-9-38(69)54(87)88)68-47(80)31(8-5-6-18-55)61-49(82)35(22-41(74)75)65-46(79)33(15-17-40(57)73)62-48(81)34(21-29-24-59-25-60-29)64-45(78)32(14-16-39(56)72)63-50(83)36(23-42(76)77)66-51(84)43(58)27(3)70/h10-13,24-27,31-38,43-44,70-71H,4-9,14-23,55,58H2,1-3H3,(H2,56,72)(H2,57,73)(H,59,60)(H,61,82)(H,62,81)(H,63,83)(H,64,78)(H,65,79)(H,66,84)(H,67,85)(H,68,80)(H,74,75)(H,76,77)(H,87,88)/t26-,27+,31-,32-,33-,34-,35-,36-,37-,38-,43-,44-/m0/s1 InChIKey: VTJZYUHCIFXLFY-DKZBFBCOSA-N Information concerning Angiotensin-Converting Enzyme (ACE) is available in MEROPS database of proteolytic enzymes (http://merops.sanger.ac.uk/) ID: M02-001
Additional Detail Fields 1 fields
10